Condition
Arachnophobia
Total Trials
8
Recruiting
1
Active
1
Completed
5
Success Rate
83.3%-3% vs avg
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
12.5%
1 terminated out of 8 trials
Success Rate
83.3%
-3.2% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results83% success
Data Visualizations
Phase Distribution
8Total
Not Applicable (8)
Trial Status
Completed5
Terminated1
Recruiting1
Unknown1
Trial Success Rate
83.3%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Showing 8 of 8 trials
NCT05424250Not ApplicableCompleted
Optimizing Exposure Using Occasional Aversive Imagery in Spider Fearful Individuals
NCT06182709Not ApplicableCompleted
Feasibility of an Online Modeled Exposure in Spider Fearful Individuals
NCT06302868Not ApplicableRecruitingPrimary
Telemedicine-Based Virtual Reality Clinic for the Treatment of Phobias
NCT04470882Not ApplicableCompleted
Use of Safety Behaviors in Exposure Therapy for Arachnophobia
NCT04019054Not ApplicableTerminatedPrimary
TMS and Exposure Therapy
NCT04663672Not ApplicableCompleted
Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy
NCT03934385Not ApplicableCompleted
Optimizing Exposure Therapy With Mental Rehearsal
NCT02584387Not ApplicableUnknown
3D Video Virtual Reality Exposure Therapy Study
Showing all 8 trials